探討Myc/Max調控PML之機制

The Role of Myc/Max in PML Regulation

連妃儀(Fei-I Lien)

指導教授 ： 陳瑞華

國立臺灣大學/生命科學院/生化科學研究所/碩士(2012年)

https://doi.org/10.6342/NTU.2012.10914

摘要

無資料

關鍵字

PML ； Myc/Max ； 轉錄調控 ； 轉譯後蛋白質修飾

並列摘要

The promyelocytic leukemia protein (PML) was identified in acute promyelocytic leukemia, in which chromosome translocation generates oncogenic PML-RARα fusion protein. The PML protein is essential for the assembly of PML-nuclear bodies (PML-NBs) and is a tumor suppressor. Through lentivirus-based shRNAs screening, previous study in our laboratory identified nine oncogenes and one tumor suppressor as putative regulators of PML-NBs. Using RNA interference and overexpression strategies to validate their effects on PML expression, we confirmed that Myc, Max, and Src are negative regulators of PML. We next investigated the mechanism underlying Myc/Max-induced PML downregulation. We observed that Myc/Max suppress PML mRNA expression and repress PML promoter activity. We further identified that a 0.2 kb PML promoter segment is responsible for Myc/Max binding and Myc/Max-mediated transcription repression. Besides transcriptional repression, we found that Myc/Max also accelerate PML protein turnover by increasing PML ubiquitiantion. Interestingly, this effect is not due to upregulation of previously identified PML E3 ligases RNF4 and KLHL20, but is likely mediated by a Cullin 4A/B-family of E3 ligase. In conclusion, our study identifies Myc/Max as PML negative regulators and indicates that Myc/Max regulate PML through both transcriptional and post-translational mechanisms.

並列關鍵字

PML ； Myc/Max ； transcription ； post-translational modification

參考文獻

Heuser, M., van der Kuip, H., Falini, B., Peschel, C., Huber, C., and Fischer, T. (1998). Induction of the pro-myelocytic leukaemia gene by type I and type II interferons. Mediators of inflammation 7, 319-325.

Adhikary, S., and Eilers, M. (2005). Transcriptional regulation and transformation by Myc proteins. Nature reviews Molecular cell biology 6, 635-645.

Bardos, J.I., and Ashcroft, M. (2004). Hypoxia-inducible factor-1 and oncogenic signalling. BioEssays : news and reviews in molecular, cellular and developmental biology 26, 262-269.

Battey, J., Moulding, C., Taub, R., Murphy, W., Stewart, T., Potter, H., Lenoir, G., and Leder, P. (1983). The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34, 779-787.

Bernardi, R., Guernah, I., Jin, D., Grisendi, S., Alimonti, A., Teruya-Feldstein, J., Cordon-Cardo, C., Simon, M.C., Rafii, S., and Pandolfi, P.P. (2006). PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. Nature 442, 779-785.